Security key
29415V117
Envoy Medical, Inc. - Class A Common Stock, par value $0.0001 per share (COCHW)
CUSIP: 29415V117
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Class A Common Stock, par value $0.0001 per share
- Total 13F shares
- 6,177,812
- Total 13F value
- $239,263
- Share change
- +268,154
- SEC-reported price per share
- $0.04
- Number of holders
- 34
- Value change
- +$10,079
- Number of buys
- 1
- Number of sells
- 4
- Shares outstanding
- 76,914,895
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
34
Top holders
10
COCHW full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Envoy Medical, Inc. SEC filings
Envoy Medical, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29415V117
Recent filing periods:
Ownership snapshot
Top reported holders of COCHW - Envoy Medical, Inc. - Class A Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Anzu SPAC GP I LLC
Disclosed value leader
Anzu SPAC GP I LLC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
3/4/5
13F
Lead comparable stake: 11%
13D/G row: Anzu SPAC GP I LLC
Showing 1-6 of 15 holder rows.
Quick read
Anzu SPAC GP I LLC leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Anzu SPAC GP I LLC's linked filing trail.
Comparable ownership
Top 5
Anzu SPAC GP I LLC
11%
ARISTEIA CAPITAL, L.L.C.
4.7%
Walleye Capital LLC
2.7%
Sandia Investment Management LP
0.77%
Atlas Merchant Capital LLC
0.68%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Anzu SPAC GP I LLC |
13D/G
3/4/5
10%+ Owner
|
11%
|
$3,806,377
2,718,841 shares
|
$0 | 29 Sep 2023 |
| ARISTEIA CAPITAL, L.L.C. |
13D/G
13F
Company
|
4.7%
|
$53,046
1,060,922 shares
|
$0 | 31 Mar 2025 |
| Walleye Capital LLC |
13D/G
|
2.7%
|
$28,337
566,735 shares
|
$0 | 31 Dec 2024 |
| Sandia Investment Management LP |
13F
Company
|
0.77%
|
$19,466
589,886 shares
|
— | 31 Mar 2025 |
| Atlas Merchant Capital LLC |
3/4/5
13F
10%+ Owner · Company
|
0.68%
from 13F
|
$828,000
900,000 shares
|
— | 02 Mar 2023 |
| VANGUARD GROUP INC |
13F
Company
|
0.49%
|
$513,449
394,961 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
34
Shares
6,177,812
Rows available
34
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
35
Q2 2025 holders
34
Holder diff
-1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend